MediWound
MDWD
21 hedge funds and large institutions have $26.4M invested in MediWound in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 4 closing their positions.
141% more capital invested
Capital invested by funds: $11M → $26.4M (+$15.5M)
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
11% more funds holding
Funds holding: 19 → 21 (+2)
6.9% more ownership
Funds ownership: 14.02% → 20.92% (+6.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10.4M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.89M |
| 3 |
AIC
AWM Investment Company
New York
|
+$1.8M |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$676K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$450K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$523K |
| 2 |
ACM
Altium Capital Management
New York
|
-$368K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$66.8K |
| 4 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
-$58.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$38.6K |
MDWD Hedge Fund Activity: Q1 2023 in Review
21 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in MediWound (MDWD) for Q1 2023, worth a combined $26.4M — up 141% from $11M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new MDWD positions and 4 closed out — a net gain of 2 holders — while 8 added to existing stakes and 6 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $10.4M. The largest seller was Meitav Investment House, cutting an estimated $523K.
- 21 institutional investors held MediWound (MDWD) as of Q1 2023, up from 19 in Q4 2022.
- Funds reported $26.4M of MediWound stock for Q1 2023, up 141% quarter-over-quarter.
- 6 funds opened new MediWound positions in Q1 2023 and 4 closed out, a net change of +2 holders.
- The largest MediWound buyer in Q1 2023 was Point72 Asset Management, an estimated $10.4M added.
- The largest MediWound seller in Q1 2023 was Meitav Investment House, an estimated $523K sold.
Based on aggregated 13F filings for Q1 2023.